Reply to M. K. Bos et al.
Publication
, Journal Article
Sperger, JM; Feng, FY; Armstrong, AJ; Zhao, SG; Lang, JM
Published in: J Clin Oncol
February 10, 2022
Duke Scholars
Published In
J Clin Oncol
DOI
EISSN
1527-7755
Publication Date
February 10, 2022
Volume
40
Issue
5
Start / End Page
520 / 522
Location
United States
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences
Citation
APA
Chicago
ICMJE
MLA
NLM
Sperger, J. M., Feng, F. Y., Armstrong, A. J., Zhao, S. G., & Lang, J. M. (2022). Reply to M. K. Bos et al. J Clin Oncol, 40(5), 520–522. https://doi.org/10.1200/JCO.21.02238
Sperger, Jamie M., Felix Y. Feng, Andrew J. Armstrong, Shuang G. Zhao, and Joshua M. Lang. “Reply to M. K. Bos et al.” J Clin Oncol 40, no. 5 (February 10, 2022): 520–22. https://doi.org/10.1200/JCO.21.02238.
Sperger JM, Feng FY, Armstrong AJ, Zhao SG, Lang JM. Reply to M. K. Bos et al. J Clin Oncol. 2022 Feb 10;40(5):520–2.
Sperger, Jamie M., et al. “Reply to M. K. Bos et al.” J Clin Oncol, vol. 40, no. 5, Feb. 2022, pp. 520–22. Pubmed, doi:10.1200/JCO.21.02238.
Sperger JM, Feng FY, Armstrong AJ, Zhao SG, Lang JM. Reply to M. K. Bos et al. J Clin Oncol. 2022 Feb 10;40(5):520–522.
Published In
J Clin Oncol
DOI
EISSN
1527-7755
Publication Date
February 10, 2022
Volume
40
Issue
5
Start / End Page
520 / 522
Location
United States
Related Subject Headings
- Oncology & Carcinogenesis
- 3211 Oncology and carcinogenesis
- 1112 Oncology and Carcinogenesis
- 1103 Clinical Sciences